Tuesday, August 30, 2016

OncoMed Pharmaceuticals Completes Enrollment of Phase 2 PINNACLE Clinical Trial of Tarextumab in Small Cell Lung Cancer

… the treatment of small cell lung cancer (SCLC).  The PINNACLE study enrolled … Small Cell Lung Cancer
According to the American Cancer Society, lung cancer (both small … Untreated Extensive Stage Small Cell Lung Cancer).  Tarextumab is part of OncoMed …
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)